This article is brought to you in association with the European Commission. The European Commission has fined Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea and Transo-Pharm a total of €13,4 million for participating in a cartel concerning an important pharmaceutical ingredient. C2 PHARMA was not fined as it revealed the cartel to the Commission under the […]Commission fines pharma companies €13,4 million in antitrust cartel settlement
October 20, 2023 by Leave a Comment
This article is brought to you in association with the European Commission. The European Commission has fined Alkaloids of Australia, Alkaloids Corporation, Boehringer, Linnea and Transo-Pharm a total of €13,4 million for participating in a cartel concerning an important pharmaceutical ingredient. C2 PHARMA was not fined as it revealed the cartel to the Commission under the […]In Africa’s free trade area, investment in pharmaceuticals means impact and profit
March 29, 2023 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Landry Signé, Senior Fellow, Global Economy and Development Program, Brookings Institution, Chido Munyati, Head of Regional Agenda, Africa, World Economic Forum The COVID-19 pandemic brushed away any doubt as to the importance of functioning and productive pharmaceutical industries. Countries […]6 ways the pharmaceutical industry can reduce its climate impact
November 28, 2022 by 1 Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Jayasree K. Iyer, CEO, Access to Medicine Foundation Health and climate are inextricably linked, from the impact of extreme weather on food security to air pollution due to wildfires or the growing spread of infectious diseases. Wherever we […]Affordable, accessible and safe medicines for all: the Commission presents a Pharmaceutical Strategy for Europe
November 25, 2020 by Leave a Comment
This article is brought to you in association with the European Commission. The Commission has today adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU’s pharmaceutical industry. The Strategy will allow Europe to cover its pharmaceutical needs, […]From the boardroom to the consulting room: pharma’s role in curing gender bias
March 6, 2020 by 1 Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Jayasree K. Iyer, Executive Director, Access to Medicine Foundation • Pharma companies putting greater priority on women makes sense financially and in terms of healthcare impact. • Women in low-income countries bear a disproportionate disease burden. • More […]Quelling antimicrobial resistance: a clinico-pharmacological exigency
December 16, 2019 by Leave a Comment
This article was exclusively written for The European Sting by Mr. Pat Ashinze, an Igbo-Yoruba Nigerian penultimate medical student at The University of Ilorin, Ilorin, Nigeria. He is affiliated to the International Federation of Medical Students Associations (IFMSA), cordial partner of The Sting. The opinions expressed in this piece belong strictly to the writer and do not […]Pharmaceuticals in the environment: Commission defines actions to address risks and challenges
March 12, 2019 by Leave a Comment
This article is brought to you in association with the European Commission. The European Commission adopted yesterday a Communication outlining a set of actions addressing the multifaceted challenges that the release of pharmaceuticals poses to the environment. The “Strategic Approach to Pharmaceuticals in the Environment” that the Commission presents today, identifies six action areas concerning all […]How we can win the war against antibiotic resistance
January 10, 2019 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Kristina Lagerstedt, Founder and CEO, 1928 Diagnostics In 1945, Sir Alexander Fleming received the Nobel Prize in Medicine for the discovery of penicillin. In Sir Alexander’s acceptance remarks, he spoke of the responsibility that accompanied that discovery, namely that […]Sponsored content: when QUALITY meets OPEX in manufacturing
July 30, 2015 by Leave a Comment
BARCELONA, July 15, 2015 – QUALITY is a key driver in timely product launches, enhancing a company’s reputation and maximizing shareholder value. Therefore Fleming Europe has decided to exploit the potential of producing an uninterrupted supply of high-quality medicine for patients in a challenging regulatory environment. How successful are you in facilitating continuous improvement of […]
